Cochrane Abstracts
Olanzapine in long‐term treatment for bipolar disorder
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Olanzapine in Long‐term Treatment for Bipolar Disorder." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436810/1/Olanzapine_in_long‐term_treatment_for_bipolar_disorder.
Olanzapine in long‐term treatment for bipolar disorder. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436810/1/Olanzapine_in_long‐term_treatment_for_bipolar_disorder. Accessed December 31, 2024.
Olanzapine in long‐term treatment for bipolar disorder. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436810/1/Olanzapine_in_long‐term_treatment_for_bipolar_disorder
Olanzapine in Long‐term Treatment for Bipolar Disorder [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436810/1/Olanzapine_in_long‐term_treatment_for_bipolar_disorder.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Olanzapine in long‐term treatment for bipolar disorder
ID - 436810
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436810/1/Olanzapine_in_long‐term_treatment_for_bipolar_disorder
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
